Ming-Lung Yu, MD, PhD is a Distinguished Professor at the College of Medicine, Kaohsiung Medical University, Taiwan. Professor Yu graduated from the College of Medicine at Kaohsiung Medical Universityin 1989 before going on to obtain a PhD from the Graduate Institute of Clinical Medicine in 2000. Professor Yu,a board-certified internist and gastroenterologist,is currently teaching at the Kaohsiung Medical University and Kaosiung Medical University Hospital where he is holding the leading role of Hepatitis Center and Hepatobiliary section, Department of Internal Medicine. Currently, he is also a Visiting Professor at Liver Center, Division of Gastroenterology, Massachusetts General Hospital, Boston, MA, USA.

· Molecular epidemiology of hepatitis C virus infection 

· Host epigenetic/genetic studies in chronic hepatitis C patients

· Personalized therapy of patients with acute and chronic hepatitis C

· Pathogenesis and treatment of hepatocellular carcinoma

· Molecular/epigenetic/genetic studies of hepatocellular carcinoma

· The effect of mass hepatitis B virus vaccination in 

· Treatment of chronic hepatitis B patients

Dr. Alessandro Federico is Associate Professor in Hepatology and Gastroenterology at the Medicine and Surgery Faculty of University of Campania "L. Vanvitelli" (Italy).

He holds a Ph.D. in Digestive and Nutritional Physiopathologyfrom University of Campania "L Vanvitelli" and he is also Specialist in Gastroenterology and Digestive Endoscopy.

Notably, Prof. Federico has published more than 140 scientific publications and is a named inventor of 1 issued patent.

• Dr. Alessandro Federico research interest in the role of radical species and nitric oxide in chronic liver and gastrointestinal diseases and the role of food and nutrition in digestive pathology

In 1978, Dr. Tetsuya Mine graduated University of Tokyo School of Medicine and major in Gastroenterology and Hepatology. Then, he worked as the clinician at Tokyo University Hospital. As the same time, he wrote many fundamental papers. Thereafter, he moved from the Tokyo University to Tokai University as Professor.

・Viral Hepatitis

・Endoscopy

・Liver Cirrhosis

・Colonoscopy

・HCC

·         General surgeon and coloproctologist specialist at Santa Marcelina Hospital

·         Semiology and medical propaedeutics professor at Santa Marcelina College

·         Coordinating member of general surgery service at Santa Marcelina Itaim Paulista

·         Full member of coloproctologist brazilian society

·         Currently has been taking a doctoral degree at São Paulo University Medical College Hospital

·         Pelvic floor disorder: fecal incontinence, intestinal constipation

·         Assessment of obese people with fecal incontinence symptoms

·         Colorectal cancer

·         Liver metastasis from colorectal cancer 

• Accomplished and seasoned executive with more than 20 years of highly successful research and education experience in the academia and industry, in particular academic higher education and scholarship.
• Accomplished researcher, teacher and administrator in higher education, Dr. Banan came to Windsor University after serving 4 years as Executive Director of Research and Senior Vice President of Research Development for Emerge and the University of South Carolina Greenville, with previous stints as Chief Science Officer and Senior Vice President Research & Economic Developmentor Global Executive Head of Research at Emerge, Abbott and Rush University at Chicago.
• Served on over 50 professional committees and over 100 national and international organizations, volunteer boards, government/public health councils, industry, and academia.
• Secured well over $350 million of research and education funding from various sources, including private industry, government (NIH, HHS, CDC, DARPA), and venture capital nationally and globally.
• Overall, he is a highly seasoned researcher and academic educator with proven track-record of successfully leading innovative Academic Research and Education programs, nationally and globally.
• Author of 300+ peer-reviewed research publications, book chapters and abstract presentations as well as invited national and international presentations; and inventor of several worldwide patents.

• Gastroenterology
• Translational Medicine
• Personalized Health Care
• Digestive diseases
• Medicine
• Physiology
• Biomedical Sciences
• Pharmacology

Professor Dr. VirojWiwanitkitis currently working as a medical professor and Asian Scholar. He graduated in medical doctor (M.D). (Honors) and works in medical academics in many universities. At present he is appointed as a visiting University Professor, Hainan Medical University, China ;  visiting professor, Faculty of Medicine, University of Nis, Serbia ; adjunct professor, Joseph Ayobabalola University, Nigeria and Professor, Senior Expert, SurinRajabhat University, Thailand. He has many international publications in medical field.  His research interest includes tropical medicine and public health, Laboratory medicine, clinical biochemistry, molecular biology and microbiology. At present, he is the medical scientist who has more than 1,800 article publications and he has the most number (the first world rank) of international publications as the first and the last author.  He also serve as editor in chief and editorial board of about 100 international medical journals published from several countries around the world.

·         Tropical medicine

·         Laboratory science (biomedical)

·         Nanoscience and nanotechnology

·         Bioinformatics and medical engineering

·         Family medicine, social medicine and public health

·         Advanced Endoscopy

·         biliary tree

·         obesity.

• Professor ZhigangGuo is a well-known academic/researcher/scientist. He received his Ph.D. degree on biochemistry and molecular biology in Nanjing University, 2005. After graduation, he joined Tanox Biopharmaceuticals as a research scientist and group leader for antibody development in 2005. From 2005 to 2012, Dr. ZhigangGuo went to National Medical Center and Beckman Research Institute, City of Hope, to explore his research on DNA damage repair and cancer. He published more than 10 professional papers on Journals included in SCI. In particular, he and his colleagues discovered Flap endonuclease 1(FEN1), the founding member of the structure specific nuclease family. 

• Dr. ZhigangGuo was hired by Nanjing Normal University as professor and Ph.D. advisor in 2011. In December 2016, He was elected as vice dean of School of Life Sciences, Nanjing Normal University. He is also the executive director and chair of Biochemistry and Molecular Biology Society, Jiangsu, China.

• His Recent research interest is focused on DNA damage repair and anti-tumor. Extensive research was conducted regarding base excision repair mechanisms and enzymes involved. His team devotes to developing new cancer diagnostic marker using DNA repair key enzymes and high-throughput screening for relative small molecular inhibitors. In 2016-2017, there’s been 8 papers published on journals like Ebiomedicine, Oncogene, Oncotarget, etc. 

• DNA Damage Repair and anti-tumor Research nucleases, which play critical roles in DNA replication and repair as strong mutator genes and cancer etiological factors
• discover new diagnostic markers for cancer and screen for drugable small molecular inhibitors using high-throughput virtual screening.   

• Antibody Engineering and Therapeutic Antibody Development

Dr. Cheng Zhang graduated from Xinagya School of Medicine, Central South University, China in 1995 with my MD degree.  Afterwards, I had completed Otolaryngology resident and fellowship training in Beijing Hospital in China.  In 2005, I obtained my Ph.D degree in the field of molecular biology at the School of Pharmacy, University of Southern California in Los Angeles, USA.  Then I started my medicine residency training in the Greater Baltimore Medical Center, affiliated to the Johns Hopkins University at Baltimore, MD USA.  In 2009 after I completed the medicine residency training, I started gastroenterology fellowship training in Beth Israel Deaconess Medical Center, Harvard Medical School, Boston MA USA.   Presently, I am an assistant professor in the Ohio State University. 

• translational and basic science research in inflammatory bowel disease

• outcome clinical research in inflammatory bowel disease.  

Dr. Nihar Shah completed his medical training at the Smt.N.H.L.Municipal Medical College, Ahmedabad, India. Upon completition of his medical degree, he relocated to the United States and completed his Internal Medicine Residency, Gastroenterology and Hepatology Fellowship at Seton hall University School of health and Medical Sciences, NJ. He currently serves as an Assistant Professor, Section of Gastroenterology, in the Department of Medicine at Joan C. Edward School of Medicine, Marshall University where he serves an integral role in training medical students and residents in the fields of Gastroenterology and Hepatology. He was awarded Certificate of achievement in endoscopy education by American Society of Gastrointestinal Endoscopy in 2015 and was also elected as a fellow of American College of Physicians. He is board certified in Internal Medicine, Gastroenterology and Obesity Medicine.

• Endoscopic treatment of Gastroesophageal Reflux Disease
• Endoscopic Bariatrics
• Quality improvement for colonoscopy
• Liver and Billiary Diseases

Dr. Somchai Amornyotin graduated at the Faculty of Medicine Siriraj Hospital, Mahidol University in 1989. He became the staff of the Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok, Thailand in 1996. Until 2004 he became the associate professor of the Department of Anesthesiology, Faculty of Medicine Siriraj Hospital, Mahidol University. From 2005 until 2009 he was the chief of Anesthesiology Division of Siriraj GI Endoscopy Center, Faculty of Medicine Siriraj Hospital, Mahidol University. His first scientific paper was published in Thailand in 1999.

He has practiced anesthesia for gastrointestinal endoscopy since 2002. He was the committee of Siriraj Gastrointestinal Endoscopy Center, Faculty of Medicine Siriraj Hospital in 2005. More than 50 of his articles have been published in Thai and international medical journals. Dr. Amornyotin is a member and committee of the Royal College of Anesthesiologists of Thailand, the Gastroenterological Association of Thailand and many scientific societies. He is the reviewer and editor of many international journals.  

• Anesthesia for gastrointestinal endoscopy
• Total intravenous sedation (TIVA)
• Target controlled infusion (TCI)
• Sedation for pediatric patients
• Anesthesia outside the operating room
• Ambulatory anesthesia
• Airway management
• Acute postoperative pain management

I graduated from Nagoya City University in 1985, and took the degree of M.D. While I worked as a clinician for several years, I was interested in the molecular biology of the hepatitis virus. I learned the molecular biological basics in the study of the influenza virus as a research resident of department of virology, Nagoya City University, at first. I took the degree of M.D., PhD. in 1994. After then, I researched several hepatitis viruses in Dr. Mayumi's lab, Immunology Division, Jichi Medical School (Japan), from 1994 through 1996. From 1997 through 1999, I researched hepatitis C virus in Katz’s lab, Department of Microbiology, University Washington in Seattle (USA). I have continued clinical studies and basal science researches, in hepatology and pancreatology, after return to Japan. In late years, what I have researched most eagerly is the study of the functions of p53 splicing isoforms which the functions have not been yet known to enough in liver. Recently, we clarified the function of delta40p53, which is one of the p53 isoforms, in hepatocellular carcinoma.

·         Molecular biology of pathogenesis and senescence in hepatocellular carcinoma.

·         Signal transduction in hepatocytes.

·         Clinical studies of chronic liver diseases.

·         Development of the new medicine for liver fibrosis.

·         Development of the new medicine for chronic pancreatitis.

Oronzo Brunetti graduated cum laude in 2008 from the University of Bari School of Medicine, Bari, Italy. Since graduation, he has become involved in studies on translational research in solid tumors.

Since 2014, he is a member of AIOM (the Italian Association of Medical Oncology).

Since 2015, he is a member of the Italian Group for Diagnosis and Treatment of Biliary Cancer (GICO).

From 2016 he has been involved in the elaboration of guidelines of exocrine pancreatic carcinoma for the AIOM.

He has published 20 papers in peer-reviewed journals, most of them on gastrointestinal cancers.

He is actually involved a research project for identification of prognostic/predictive biomarkers in pancreatic, biliary, and hepatocellular cancer.

• Clinical trials
• Prognostic/predictive biomarkers
• Pancreatic cancer
• Biliary tract cancer
• Hepatocellular cancer
• Translational medicine